
A developer of Covid-19 vaccines and an artificial intelligence company are building a system to quickly detect dangerous SARS-CoV-2 variants. . . . → Read More: Biotech, AI Company Partner on Covid-19 Alert System
|
|||||
![]() A developer of Covid-19 vaccines and an artificial intelligence company are building a system to quickly detect dangerous SARS-CoV-2 variants. . . . → Read More: Biotech, AI Company Partner on Covid-19 Alert System ![]() A company using artificial intelligence to design drugs for personalized treatments is partnering with drug maker Sanofi in a deal valued at $5.3 billion. . . . → Read More: Sanofi Partners in $5.3B Precision Drug Discovery Deal ![]() A new company developing a therapy using light-sensitive proteins for treating an inherited eye disorder is raising $6 million in seed funds. . . . → Read More: Optogenetics Start-Up Raises $6M for Retinal Therapy ![]() GlaxoSmithKline is funding a joint research center at University of Oxford to advance precision medical technologies, beginning with neurological disorders. . . . → Read More: Oxford, GSK Partner on New Tech for Neuro Diseases ![]() Alphabet, the parent company of Google, is forming a new enterprise using artificial intelligence techniques to discover new protein-based drugs. . . . → Read More: Alphabet Forms AI Drug Discovery Company ![]() A company is developing a nasal spray for epilepsy symptoms with a cannabis extract delivered in nanoscale polymer particles to the brain. . . . → Read More: Delivery Tech Licensed for CBD Epilepsy Nasal Spray ![]() A developer of drugs from psychedelic compounds for mental health conditions is raising $80 million in its second venture funding round. . . . → Read More: Psychedelic Therapy Company Raises $80M in New Funds ![]() A venture philanthropy group is funding an initiative to find digital data indicators of early onset of Alzheimer’s disease and other forms of dementia. . . . → Read More: Alzheimer’s Digital Biomarkers Project Gains New Funds ![]() Researchers developed a biodegradable polymer for printed implant scaffolds that in lab rodents maintains its shape to encourage cell and tissue growth. . . . → Read More: 3-D Printed Scaffold Helps Regrow Soft Tissue ![]() GlaxoSmithKline and biotechnology company Alector Inc. agreed to co-develop two synthetic antibodies for treating neurodegenerative disorders. . . . → Read More: GSK, Biotech Partner on Neuro Antibodies in $2.2B Deal |
|||||
Copyright © 2022 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |